Amblyopia digital

therapy for children

AmblyoPlay Clinically Proven to Improve Vision and Motor Skills in School-Aged Patients

A new milestone has been reached in digital pediatric eyecare. Smart Optometry has announced the first peer-reviewed AmblyoPlay clinical study, confirming that its digital therapeutic platform delivers measurable improvements in visual acuity, stereopsis, oculomotor control and motor coordination in children with anisometropic amblyopia. 

For practitioners searching for effective digital amblyopia therapy for children, the findings provide long-awaited scientific clarity.

The AmblyoPlay Vision Therapy Program for Pediatric Needs

The AmblyoPlay vision therapy program uses dichoptic stimulation and adaptive, game-based tasks to activate both eyes simultaneously. The approach is designed to rehabilitate binocular vision rather than rely solely on monocular training. This stands in contrast to traditional patching, which often struggles with compliance and is less effective in older children.

Amblyopia caused by unequal refractive error disrupts binocular integration and leads to chronic cortical suppression. By challenging visual, oculomotor and sensorimotor systems together, the platform offers a broader therapeutic model that aligns with emerging scientific insights into how the condition affects the developing brain.

Study Design Confirms Measurable Benefits Over Six Months

The AmblyoPlay clinical study was conducted at Istanbul Medipol University and enrolled twenty-nine children aged seven to thirteen. Fourteen used AmblyoPlay in daily home sessions while fifteen formed an untreated control group. Outcomes were measured at baseline, one month, three months and six months.

Key improvements include:

• Visual acuity improved from 0.23 to 0.08 logMAR, equal to roughly one and a half lines.

• Stereopsis improved from 300 arcseconds to 45 arcseconds, showing restored depth perception.

• Oculomotor performance improved through reduced saccadic latency and increased pursuit and optokinetic gain.

• Motor coordination improved on BOT-2 balance and upper-limb tests, confirming benefits beyond visual function.

• Controls showed no comparable changes, highlighting the impact of digital amblyopia therapy for children through AmblyoPlay.

These results position the AmblyoPlay vision therapy program as a comprehensive solution that enhances multiple visual and motor pathways.

AmblyoPlay Clinical Study: A Breakthrough for Eyecare

The publication represents the first peer-reviewed scientific validation of the platform in a real-world pediatric population. It offers concrete evidence that school-aged children can benefit from digital amblyopia therapy, challenging long-standing assumptions that older children respond poorly to treatment.

A Growing Future for Digital Amblyopia Therapy for Children

Since its creation in 2018, AmblyoPlay has been used by tens of thousands of families around the world. The newly published AmblyoPlay clinical study provides the scientific foundation needed for wider adoption among optometrists, ophthalmologists and vision therapy specialists. It also signals a broader shift toward multimodal rehabilitation in amblyopia management, where binocular, oculomotor and sensorimotor systems are treated together rather than in isolation.

Smart Optometry states that the findings will guide future development and deepen collaboration with clinical and academic partners across the industry.